ÖNER, Ç. And ÇOLAK, E. 2021. Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma. EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.5, no.2 , 117-122.

ÖNER, Ç., & ÇOLAK, E., (2021). Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma. EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.5, no.2, 117-122.

ÖNER, ÇAĞRI, And ERTUĞRUL ÇOLAK. "Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma," EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.5, no.2, 117-122, 2021

ÖNER, ÇAĞRI And ÇOLAK, ERTUĞRUL. "Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma." EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.5, no.2, pp.117-122, 2021

ÖNER, Ç. And ÇOLAK, E. (2021) . "Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma." EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , vol.5, no.2, pp.117-122.

@article{article, author={ÇAĞRI ÖNER And author={ERTUĞRUL ÇOLAK}, title={Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma}, journal={EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY}, year=2021, pages={117-122} }